Blocking Autophagy Key to Treating Resistant Tumors?
VANCOUVER, British Columbia – The industry is redoubling its efforts to discover specific inhibitors of autophagy – the route by which cells degrade and recycle proteins – as evidence mounts from preclinical research and academic trials of the therapeutic potential of blocking that process.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter